These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 36910900)

  • 21. Recent developments in the surgical management of benign prostatic hyperplasia.
    Jepsen JV; Bruskewitz RC
    Urology; 1998 Apr; 51(4A Suppl):23-31. PubMed ID: 9586593
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aquablation of the prostate for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.
    Hwang EC; Jung JH; Borofsky M; Kim MH; Dahm P
    Cochrane Database Syst Rev; 2019 Feb; 2(2):CD013143. PubMed ID: 30759311
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Temporary implantable nitinol device (TIND): a novel, minimally invasive treatment for relief of lower urinary tract symptoms (LUTS) related to benign prostatic hyperplasia (BPH): feasibility, safety and functional results at 1 year of follow-up.
    Porpiglia F; Fiori C; Bertolo R; Garrou D; Cattaneo G; Amparore D
    BJU Int; 2015 Aug; 116(2):278-87. PubMed ID: 25382816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Surgical treatment of BPO: Standard and innovations].
    Robert G; de la Taille A; Descazeaud A
    Prog Urol; 2018 Nov; 28(15):856-867. PubMed ID: 30297185
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanical and Ablative Minimally Invasive Techniques for Male LUTS due to Benign Prostatic Obstruction: A Systematic Review according to BPH-6 Evaluation.
    Cantiello F; Fimognari D; Di Mauro M; Crocerossa F; Carbonara U; Ferro M; De Cobelli O; Lucarelli G; De Nunzio C; Morgia G; Damiano R; Autorino R; Porpiglia F; Russo GI
    Urol Int; 2021; 105(9-10):858-868. PubMed ID: 33849045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Are all procedures for benign prostatic hyperplasia created equal? A systematic review on post-procedural PSA dynamics and its correlation with relief of bladder outlet obstruction.
    Bhat A; Blachman-Braun R; Herrmann TRW; Shah HN
    World J Urol; 2022 Apr; 40(4):889-905. PubMed ID: 34212237
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emerging minimally invasive transurethral treatments for benign prostatic hyperplasia: a systematic review with meta-analysis of functional outcomes and description of complications.
    Manfredi C; Arcaniolo D; Spatafora P; Crocerossa F; Fusco F; Verze P; Fiori C; Damiano R; Cindolo L; DE Sio M; Otero JR
    Minerva Urol Nephrol; 2022 Aug; 74(4):389-399. PubMed ID: 34308611
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Online Engagement with Surgical Treatments for Benign Prostatic Hyperplasia: Are Minimally Invasive Surgical Therapies Outpacing the Gold Standard?
    Lucas MI; Diaz P; Escobedo FJ; Limbrick BJ; Scotland KB
    J Endourol; 2022 Apr; 36(4):554-561. PubMed ID: 34779667
    [No Abstract]   [Full Text] [Related]  

  • 29. Minimally invasive prostatic urethral lift: surgical technique and multinational experience.
    McNicholas TA; Woo HH; Chin PT; Bolton D; Fernández Arjona M; Sievert KD; Schoenthaler M; Wetterauer U; Vrijhof EJ; Gange S; Montorsi F
    Eur Urol; 2013 Aug; 64(2):292-9. PubMed ID: 23357348
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Novel minimally invasive treatment options for male lower urinary tract symptoms].
    Magistro G; Westhofen T; Stief C; Gratzke C
    Aktuelle Urol; 2018 Aug; 49(4):339-345. PubMed ID: 30086592
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Newer Minimally Invasive Treatment Modalities to Treat Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia.
    Dahm P; MacDonald R; McKenzie L; Jung JH; Greer N; Wilt T
    Eur Urol Open Sci; 2021 Apr; 26():72-82. PubMed ID: 34337510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prostatic urethral lift (UroLift) versus convective water vapor ablation (Rezum) for minimally invasive treatment of BPH: a comparison of improvements and durability in 3-year clinical outcomes.
    Elterman D; Shepherd S; Saadat SH; Alshak MN; Bhojani N; Zorn KC; Rijo E; Misrai V; Lajkosz K; Chughtai B
    Can J Urol; 2021 Oct; 28(5):10824-10833. PubMed ID: 34657655
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emerging, newly-approved treatments for lower urinary tract symptoms secondary to benign prostatic hypertrophy.
    Pham H; Sharma P
    Can J Urol; 2018 Apr; 25(2):9228-9237. PubMed ID: 29679999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Revival of thermotherapy for benign prostatic hyperplasia.
    Djavan B; Kazzazi A; Bostanci Y
    Curr Opin Urol; 2012 Jan; 22(1):16-21. PubMed ID: 22080873
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Minimally Invasive Therapy: What Is The Status In 2021 - What's Coming, What's Going?].
    Franz J; Gratzke C; Miernik A
    Aktuelle Urol; 2022 Jun; 53(3):231-239. PubMed ID: 35231939
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Office-based therapies for benign prostatic hyperplasia : Update on new minimally invasive surgery therapies].
    Baboudjian M; Pradere B
    Prog Urol; 2021 Nov; 31(14):931-936. PubMed ID: 34456141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is it time to offer True Minimally Invasive Treatments (TMIST) for BPH? - A review of office-based therapies and introduction of a new technology category.
    Elterman DS; Zorn KC; Chughtai B; Bhojani N
    Can J Urol; 2021 Apr; 28(2):10580-10583. PubMed ID: 33872553
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The new kids on the block: prostatic urethral lift (Urolift) and convective water vapor energy ablation (Rezūm).
    Magistro G; Weinhold P; Stief CG; Gratzke C
    Curr Opin Urol; 2018 May; 28(3):294-300. PubMed ID: 29538166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An evaluation of the economic costs and patient-related consequences of treatments for benign prostatic hyperplasia.
    DiSantostefano RL; Biddle AK; Lavelle JP
    BJU Int; 2006 May; 97(5):1007-16. PubMed ID: 16542339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. First- and Second-Generation Temporary Implantable Nitinol Devices As Minimally Invasive Treatments for BPH-Related LUTS: Systematic Review of the Literature.
    Amparore D; De Cillis S; Volpi G; Checcucci E; Manfredi M; Morra I; Di Dio M; Fiori C; Porpiglia F;
    Curr Urol Rep; 2019 Jul; 20(8):47. PubMed ID: 31278441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.